167 filings
Page 7 of 9
8-K
o4roa ene53
29 Jul 14
Cempra, Inc. Reports Second Quarter 2014 Financial and Operating Results
12:00am
8-K
20l13o
2 Jul 14
Entry into a Material Definitive Agreement
12:00am
8-K
4hclv
3 Jun 14
This presentation contains forward-looking statements regarding future events. These
12:00am
8-K
37lqvad
29 May 14
Departure of Directors or Certain Officers
12:00am
8-K
w8o66x8 2vw
22 May 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
9pwx9lvp
8 May 14
Other Events
12:00am
8-K
xzr0g b2u
6 May 14
Cempra Presents Late-Breaker on Solithromycin’s Anti NASH
12:00am
8-K
k38vnh 3zo52l5ggua
29 Apr 14
Cempra, Inc. Reports First Quarter 2014 Financial and Operating Results
12:00am
8-K
0z9cpc
2 Apr 14
Cempra to Present Late-Breaker on Solithromycin Reducing Inflammation in an Animal Model for Cancer Chemotherapy-Induced Lung Injury
12:00am
8-K
chnwc
27 Feb 14
Results of Operations and Financial Condition
12:00am
8-K
8ei 67n5ns
20 Feb 14
Other Events
12:00am
8-K
7hmyx
11 Feb 14
Other Events
12:00am
8-K
72uwgom9ia5eyf98gqvm
16 Dec 13
Other Events
12:00am
8-K
zt4jfneizf6vgfd7
27 Nov 13
Departure of Directors or Certain Officers
12:00am
8-K
wsgpxtna7lf134q
30 Oct 13
Cempra, Inc. Receives U.S. Orphan Drug Designation for Taksta™ for Treatment of
12:00am
8-K
j0clrv 7h7
29 Oct 13
Cempra, Inc. Reports Third Quarter 2013 Financial and Operating Results
12:00am
8-K
2225z2lnouy1
13 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
7zr11y3 0513ygc
30 Jul 13
Cempra, Inc. Reports Second Quarter 2013 Financial and Operating Results
12:00am
8-K
5v8 n6hopqhka6
9 Jul 13
Entry into a Material Definitive Agreement
12:00am
8-K
lj9 5g27dpk4dem
19 Jun 13
Other Events
12:00am